Taskforces

Chair:
Luciano Sposato
Vice Chair:
Cecilia Bahit

Members:
Sheila Martins
Max J Hilz
Sara Aspberg
Jan Scheitz
Mary Sheppard
Santosh Murthy
Cheng Yang Hsieh
Edip Gurol

Purpose:
To help improve cooperation between cardiology and stroke services at hospitals around the world, especially in lower resourced countries

Chair:
Edip Gurol
Vice Chair:
Hsin-Hsin Tsai

Members:
Amy Towfighi
Bo Norrving
Dong Eog Kim
Eitan Auriel
Hugh Marcus
Kazunori Toyoda
Meike Vernooij
Prashant Sanders
Stéphanie Debette

Purpose:
To bridge these gaps to improve the understanding of cSVD and VCI within the medical and lay communities and to facilitate translational multidisciplinary work in the field of cSVD.

Chair: Sheila Martins, MD, PhD, Chair of the Taskforce, WSO President, Neurology
(Universidade Federal do Rio Grande do Sul/Hospital de Clínicas de Porto Alegre, Hospital Moinhos de Vento, Brazil)

Co-Chairs:

Carlos Molina, MD, Co-Chair of the Taskforce, Neurology
(Hospital Vall d'Hebron, Spain)

Raul Nogueira, MD, Co-Chair of the Taskforce,
Neurointerventionalist (University of Pittsburg, US)

Executive Members

Robert Mikulik
Marc Ribó
Luciano A. Sposato
Jeyaraj Pandian
Violiza Inoa
Sean Savitz
Valeria Caso
Taskeen Khan
Craig Anderson

Educational Program

Gustavo Saposnik
Octávio Marques Pontes-Neto
Maria Epifania Collantes
Miguel Barboza Elizondo

Early Carreer Group

Gisele Sampaio Silva

Purpose: To drive the global implementation of evidence-based stroke care across all levels of the continuum of care, focusing on prevention, acute care, and rehabilitation.

Co-chairs
Dr. Renyu Liu
Dr. Jing Zhao

Members:
Tony Rudd
Renyu Liu
Zhao Jing
Gary Ford
David Waters
Li Dou, MD
Rita Melifonwu
Grethe Andersen
Siju V Abraham

Purpose:
To reduce the global burden of stroke with a special focus in prehospital stroke care

Back to the top

Our partners and sponsors

Achieving our vision of a life free from stroke is a task that WSO cannot achieve alone. We are committed to building our partnerships at the global, regional and national level to scale up and deliver improvements in prevention, treatment and support to reduce the burden of stroke.